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ABSTRACT
CONTEXT AND OBJECTIVE: Several studies have evaluated the role of low 25-hydroxyvitamin D (25OHD3) 
in the pathogenesis of type 2 diabetes (T2DM) and have presented controversial results. The metabolic 
processes that culminate in T2DM begin under prediabetic conditions. Our aim was to analyze the as-
sociation between 25OHD3 and glucose metabolism in individuals who were free from but at elevated 
risk of diabetes.
DESIGN AND SETTING: Cross-sectional study at a tertiary hospital.
METHODS: Anthropometric and laboratory profiles were determined in patients with one or more of the 
following risk factors: hypertension; body mass index (BMI) ≥ 25 kg/m2; waist circumference > 80 cm for 
women and > 94 cm for men; first-degree relatives with diabetes; women with large-for-gestational-age 
newborns or with gestational T2DM; HDL-cholesterol (high density lipoprotein) < 35 mg/dl; and triglyc-
erides > 250 mg/dl. The patients were divided into two groups: one with prediabetes (abnormal fasting 
plasma glucose or oral glucose tolerance test) and the other with normal glucose (euglycemic). 
RESULTS: There was no statistically significant difference between the prediabetic group (n = 38) and 
euglycemic group (n = 15) regarding age (66.4 ± 10.6 versus 62.6 ± 9.1 years), gender (52.6 versus 73.3% 
female) and BMI (30.1 ± 4.61 versus 27.9 ± 4.7 kg/m2). Low serum levels of 25OHD3 were found in both 
groups, without any statistically significant difference between them (29.1 ± 11.8 versus 26.87 ± 9.2 ng/dl).
CONCLUSION: There was no association between 25OHD3 levels and the clinical or laboratorial vari-
ables analyzed. 
RESUMO
CONTEXTO E OBJETIVO: Vários estudos já avaliaram o papel da 25-hidroxivitamina D (25OHD3) na pato-
gênese do diabetes tipo 2 (DM2) e apresentaram resultados controversos. Os processos metabólicos que 
culminam no DM2 se iniciam no pré-diabetes. Nosso objetivo foi analisar a associação da 25OHD3 com o 
metabolismo glicêmico em indivíduos sem diagnóstico mas com alto risco para diabetes.
TIPO DE ESTUDO E LOCAL: Estudo transversal em hospital terciário.
MÉTODOS: Medidas antropométricas e laboratoriais foram determinadas em pacientes com um ou mais 
dos fatores de risco: hipertensão; índice de massa corpórea (IMC) ≥ 25 kg/m2; circunferência abdominal 
> 80 cm no sexo feminino e > 94 cm no sexo masculino; parentes de primeiro grau com diabetes; mulhe-
res com filho nascido grande para idade gestacional ou com DM2 na gravidez; colesterol HDL (high density 
lipoprotein) < 35 mg/dl e triglicerídeo > 250 mg/dl. Os pacientes foram divididos em dois grupos: um com 
pré-diabetes (glicemia de jejum ou teste de tolerância oral à glicose alterados) e outro com glicose normal 
(euglicêmicos). 
RESULTADOS: Entre pré-diabéticos (n = 38) e euglicêmicos (n = 15) não houve diferença estatística na 
idade (66,4 ± 10,6 versus 62,6 ± 9,1 anos), gênero (52,6 versus 73,3% feminino) e IMC (30,1 ± 4,61 versus 
27,9 ± 4,7 kg/m2). Baixos niveis séricos de 25OHD3 foram encontrados nos dois grupos, sem diferença 
estatística entre eles (29,1 ± 11,8 versus 26,87 ± 9,2 ng/dl).
CONCLUSÃO: Não houve associação entre os níveis de 25OHD3 e as variáveis clínicas e laboratoriais 
analisadas. 
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INTRODUCTION
The presence of vitamin D receptors (VDRs) has been described 
in pancreas β cells, adipose tissue and muscle tissue. Some studies 
on animals have suggested that vitamin D is involved in the syn-
thesis and secretion of insulin, which might indicate that lower 
serum 25-hydroxyvitamin D (25OHD3) could have an impact on 
type 2 diabetes (T2DM).1,2
Twelve million Brazilians presented T2DM in 2011, accord-
ing to official Brazilian government data, and the prevalence of low 
serum 25OHD3 has increased all over the world in the last few 
years. Recently, low serum 25OHD3 has been considered to be a 
worldwide public health issue due to its impact on many diseases.3 
Despite great sunlight exposure in Brazil, low serum 25OHD3 has 
been reported. Saraiva et al.4 and Genaro et al.5 found unsuitable 
serum concentrations in 42% of the elderly in the city of São Paulo 
and 24% of osteoporotic women. In healthy teenagers and young 
adults, the prevalence was 60% and 50% respectively.6,7
Since prediabetes is an early stage of T2DM in which the met-
abolic process has already started, prevention efforts at this stage 
have greater impact in mitigating the development of T2DM.8,9 
Several clinical studies have evaluated the role of low 25OHD3 
in the pathogenesis of T2DM, but with controversial results.10-15 
Recently, a study has looked into prediabetes and 25OHD3 
in a representative population in the United States. This study 
reported that low serum 25OHD3 levels were associated with 
prediabetes in that population, with a strong correlation when 
vitamin D levels were lower than 17 ng/ml.16
To try to prove the association between vitamin D and glucose 
metabolism, Davidson et al. conducted a randomized study on vita-
min D replacement in patients with prediabetes and hypovitamino-
sis D, and demonstrated that vitamin D replacement taken for one 
year did not have any benefit in relation to glucose metabolism.17
OBJECTIVE
Since the findings regarding the association between vitamin D 
levels and glucose metabolism continue to be conflicting, and 
because so far no studies on prediabetes and vitamin D have been 
produced in any South American country, we focused on analyz-
ing vitamin D levels in subjects who were free from diabetes but 
at elevated risk of T2DM and the correlation with glucose metab-
olism, in a tertiary-level hospital in the city of São Paulo.
METHODS
We carried out a cross-sectional study from December 2009 to 
July 2010 in an outpatient clinic in the Department of Internal 
Medicine of a tertiary-level hospital in São Paulo, Brazil. 
The subjects gave their written informed consent to partici-
pate in the study. The study was approved by the research ethics 
committee of Hospital do Servidor Público Estadual de São Paulo 
(HSPE) (protocol number 0010.338.000-08).
Inclusion criteria
The study included individuals who were free from T2DM, but with 
at least one of the following conditions that have been correlated 
with higher risk of developing diabetes mellitus: hypertension; 
body mass index (BMI) ≥ 25 kg/m2; waist circumference > 80 cm 
for women and > 94 cm for men; first-degree relatives with 
diabetes; women with large-for-gestational-age newborns or 
with gestational diabetes mellitus; fasting serum HDL-cholesterol 
< 35 mg/dl; and triglycerides > 250 mg/dl. Since the Brazilian 
population is one of the most mixed in the world, ethnic groups 
were not considered as an inclusion criterion alone.
Exclusion criteria
The exclusion criteria were defined as follows: prior diagnosis of dia-
betes mellitus; use of oral hypoglycemic agents or insulin; use of vita-
min D or calcium supplementation; and glomerular filtration rate 
lower than 30 ml/min/1.73 m2. Changes in lifestyle such as treatment 
for obesity, dyslipidemia, metabolic syndrome or any pathological 
condition did not constitute exclusion criteria. The only lipid-lower-
ing drugs that were used by some of the study subjects were statins. 
The diagnosis of diabetes mellitus was defined as random plasma 
glucose > 200 mg/dl for symptomatic patients, and for asymptom-
atic patients, two results on different days with fasting plasma glu-
cose (FPG) > 125 mg/dl or two-hour glucose ≥  200 mg/dl after 
oral administration of 75 g of glucose overload (GTT). Prediabetes 
was defined as FPG of 100-125 mg/dl or two-hour glucose of 
140-199 mg/dl after oral administration of 75 g of glucose overload. 
The diagnosis of metabolic syndrome was defined in cases of 
occurrence of three out of the following five clinical conditions: fast-
ing plasma glucose equal or higher than 100 mg/dl, blood pressure 
equal or higher than 130/85 mmHg, triglycerides equal or higher 
than 150 mg/dl, HDL < 40mg/dl in males and < 50 mg/dl in females, 
and waist circumference ≥ 102 cm (males) and ≥ 88 cm (females).
Anthropometric measurements
All anthropometric measurements were performed by a single 
observer. Weight and height were assessed while the subjects were 
wearing light clothes; waist circumference (WC) was measured at 
the midpoint between the lower costal border of the last rib and the 
upper border of the iliac crest; and hip circumference (HC) was mea-
sured at the level of the greater trochanter.
Laboratory analysis
Blood samples were collected by means of antecubital venous punc-
ture, after the subjects had spent 12 hours fasting (overnight) and after 
a five-minute rest in a seated position, in a room with no sun exposure.
Prior to FPG and the two-hour glucose analysis, the subjects 
were instructed to adhere to a high-carbohydrate diet for three days; 
not to use any laxative on the day before the test; and not to do any 
physical exertion just before the test. If individuals presented diarrhea 
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during the 48-hour period preceding the two-hour glucose test, it 
was rescheduled for another day. Individuals were also instructed 
to avoid walking and they were not allowed to smoke at any 
time during the test; ingestion of food of any kind was also pro-
hibited during the test. The plasma glucose level was determined 
using an enzymatic method.
Plasma insulin levels were measured after the 12 hours of 
overnight fasting by means of an immunometric method in a 
two-sided solid-phase chemiluminescent assay (Immulite 2000, 
Siemens TM, Los Angeles, USA). Insulin resistance (IR) was 
evaluated by means of the formula for homeostasis model assess-
ment (HOMA) of IR: HOMA-IR = (glucose x insulin)/22.5.
Serum uric acid, creatinine, triglyceride and cholesterol 
concentrations were obtained by means of standard methods. 
We also evaluated microalbuminuria (μg/min) using the chemi-
luminescence method, in samples of 24-hour urine. For the esti-
mated glomerular filtration rate (GFR), we used the modification 
of diet in renal disease (MDRD) formula.
Serum 25-hydroxyvitamin D3 levels were assessed using a 
radioimmunoassay kit (DiaSorin, Stillwater, MN, USA) in which 
the intra-assay coefficient of variation was 8.6-12.5% and the 
inter-assay coefficient of variation was 8.2-11.0%.
Statistical analysis 
Statistical analyses were performed using the GraphPad Prism 
4 software. The statistical significance level was set at P < 0.05. 
Continuous variables were expressed as the mean ± standard 
deviation or the median with interquartile range, for the variables 
with and without normal distribution, respectively. Categorical 
variables were expressed as percentages. The unpaired t test 
was used to analyze the difference between two groups, and the 
Mann-Whitney test was performed when the groups did not 
have normal distribution. Correlations were obtained through 
the Pearson or Spearman test, when appropriate.
RESULTS
We evaluated 53 subjects with a mean age of 65.3 ± 10.3 years, 
of whom 31 (58.5%) were women. The mean BMI was 29.5 ± 
4.7 kg/m2, WC 99.8 ± 12.9 cm and HC 104.3 ± 13.1 cm. The median 
number of risk factors for diabetes was 4 (4-5).  The  mean 
FG was 100.5  ± 11.2  mg/dl, GTT 132.8  ± 30.3  mg/dl, 
HDL-cholesterol 49.9  ± 12.9  mg/dl, LDL-cholesterol 122.2  ± 
36.2  mg/dl, triglycerides 146.2  ± 7.6  mg/dl and uric acid 
5.3 ± 2.4  mg/dl. The  median serum insulin level was 6.9 (4.6-
16.1)  mUI/ml, median HOMA-IR 1.9 (0.9-4.0), mean serum 
creatinine 0.9 ± 0.2 mg/dl, mean glomerular filtration rate from 
MDRD 69.2 ± 16.7 ml/min/1.73 m2, median microalbuminuria 
7.1 (3.6-10.4) µg/min and mean 25OHD3 was 28.4 ± 11.1 ng/ml.
Thirty-eight patients (71.7%) had prediabetes and 15 (28.3%) 
were euglycemic. Comparing the prediabetes group with the 
euglycemic group there were no differences in gender distribution 
(52.6 versus 73.3% females, respectively), age (66.4 ± 10.6 versus 
62.6 ± 9.1 years, respectively), frequency of hypertension (71.5 
versus 73.3%, respectively), frequency of dyslipidemia (77.7 ver-
sus 66.6%, respectively) or BMI (30.1 ± 4.6 versus 27.9 ± 4.7 kg/m2, 
respectively), as shown in Table 1.
Compared with the euglycemic group, the prediabetes 
group presented significantly higher WC (102.2 ± 11.8 versus 
94.3 ± 14.0 cm, P = 0.04, respectively), HC (106.9 ± 10.6 versus 
97.3 ± 16.3 cm, P = 0.02, respectively), uric acid (6.6 ±1.5 ver-
sus 5.1 ± 1.4 mg/dl, P = 0.003, respectively), serum insulin (9.6 
(5.4-17.9) versus 5.7 (3.3-9.0) mUI/ml, P = 0.03, respectively), 
HOMA-IR (2.6 (1.2-4.7) versus 1.4 (0.7-1.7), P =  0.01, respec-
tively) and microalbuminuria (30.6 ± 88.0 versus 5.2 ± 3.3 µg/min, 
P = 0.02, respectively), as shown in Table 2. Total choles-
terol (225.0 ± 36.3 versus 191.8 ± 37.6 mg/dl, P = 0.005), 
HDL-cholesterol (55.6 ± 17.6 versus 47.6 ± 9.9 mg/dl, P = 0.04) 
and LDL-cholesterol (144.9 ± 31.0 versus 112.9 ± 34.4 mg/dl, 
P = 0.003) were higher in the euglycemic group than in the pre-
diabetes group, respectively (Table 2). 
Low serum levels of 25-hydroxyvitamin D3 were found in 
both groups, with no difference between the prediabetes and eug-
lycemic groups (29.1 ± 11.8 versus 26.8 ± 9.2 ng/ml, respectively). 
We did not find any correlation between serum 25OHD3 and any 
anthropometric parameters (weight, BMI, WC and HC). In a sub-
analysis on BMI groups, there was no difference in 25OHD3 levels 
between subjects with BMI < 30 kg/m2 (n = 30) and BMI ≥ 30 kg/m2 
(n = 23): 25.9 ± 8.0 versus 30.6 ± 12.2 ng/ml, respectively. 
There was no correlation between 25OHD3 levels and fast-
ing glucose, GTT, serum insulin, HOMA-IR or other laboratory 
variables. In the whole group, there were 35 patients (66%) with 
three or more criteria for metabolic syndrome. We did not find 
any difference in serum 25OHD3 between groups with metabolic 
syndrome (n = 35) and without metabolic syndrome (n = 18): 
29.2 ± 11.9 versus 26.6 ± 9.7 ng/ml, respectively.
Table 1. Clinical characteristics of the prediabetic and euglycemic groups
Prediabetic group
n = 38
Euglycemic group
n = 15
P
Age (years) 66.4 ± 10.6 62.6 ± 9.1 ns
Female (%) 52.6% 73.3% ns
Hypertension (%) 71.5% 73.3% ns
Dyslipidemia (%) 77.7% 66.6% ns
Weight 78.5 ± 12.6 69.9 ± 12.7 0.03
Height (m) 1.61 ± 0.09 1.58 ± 0.07 ns
Waist circumference (cm) 102.2 ± 11.84 94.3 ± 14.0 0.04
Hip circumference (cm) 106.9 ± 10.6 97.3 ± 16.3 0.02
Waist circumference/ 
hip circumference
0.9 ± 0.06 0.9 ± 0.02 ns
Body mass index (kg/m2) 30.1 ± 4.61 27.9 ± 4.7 ns
Mean ± standard deviation.  ns = not significant.
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In our sample, we had 38 patients with age ≥ 60 years old 
and 15 with age < 60 years old. Comparison of 25OHD3 levels 
between these groups did not show any difference: 29.0 ± 12.0 
versus 27.1 ± 8.7 ng/ml, respectively.
DISCUSSION
There is evidence that 3% of the human genome is managed by 
1.25(OH)2D3, the active form of vitamin D.18 Because of the 
presence of vitamin D receptors in several tissues, vitamin D has 
been ascribed an important role in neoplasms and in the immune 
and cardiovascular systems.19-21 In addition, other observations 
indicate that hypovitaminosis D could have a relationship with 
the development of metabolic syndrome, including alteration of 
high-density lipoproteins, triglycerides and blood pressure.22,23
Some studies have provided evidence that vitamin D defi-
ciency may contribute directly to or have an adjunct effect on the 
pathogenesis of diabetes. Although these articles showed differ-
ent outcomes regarding vitamin D and diabetes, vitamin D was 
correlated with insulin production and secretion, and with reg-
ulation of signal transduction and decreased activity of glucose 
transporter-4 (GLUT 4).1,24,25
Scragg et al. confirmed that there was an association between 
low 25OHD3 and diabetes among non-Hispanic whites and 
Mexican Americans in the National Health and Nutrition 
Examination Survey (NHANES) III, and so did Liu et al. in the 
Framingham Study.10,11 The present study and others did not find 
any association after multivariable adjustments,13,14 or in sub-
group analyses on women.15
Recently, Anoop Shankar et al.16 studied the relationship between 
serum 25-hydroxyvitamin D levels and prediabetes in an American 
population, using data from NHANES III. The group with prediabetes 
comprised 42.9% females versus 55.6% in the non-prediabetes group. 
These two groups also presented statistical differences in age and 
BMI. They found a positive association between serum 25OHD3 
and prediabetes only in non-Hispanic white subjects, but not in non-
Hispanic blacks, Mexican Americans and others. The strongest asso-
ciation was with serum vitamin D lower than 17 ng/ml.
The Brazilian population is one of the most ethnically mixed 
populations in the world.26 We conducted a study on two groups 
with the same gender distribution, BMI and age. Prediabetic 
groups had higher weight circumference, hip circumference, 
serum uric acid, serum insulin, HOMA-IR and microalbumin-
uria. These data suggest that when prediabetes is diagnosed, 
metabolic events that are characteristic of diabetes have already 
begun. Total cholesterol and LDL cholesterol were higher in the 
euglycemic group probably because of the lesser use of statins.
Our study did not find any association between 25OHD3 
and prediabetes. This may be related to the number of individu-
als in our sample, given that a study that showed this relationship 
had a population-based sample.16 Moreover, despite the low lev-
els of vitamin D in our sample, only 28.3% had values lower than 
20 ng/ml (data not shown), whereas the correlation with predia-
betes that has been demonstrated in the literature occurred with 
values lower than 17 ng/ml.16 However, in a recent study on 175 
obese adolescents, of whom 60% were euglycemic, 25% predia-
betic and 15% diabetic, Las Heras et al. did not find any differ-
ence in serum 25OHD3 between these groups, or any association 
with any metabolic parameters, even though the prevalence of 
low levels of vitamin D was higher in both groups.27
Another study, on 150 obese children and adolescents living in 
the tropics, found vitamin D levels ≥ 20 ng/ml in 88.6%, with no dif-
ference in the prevalence of prediabetes in relation to the group with 
levels lower than 20 ng/ml.28 In spite of our negative results regarding 
the correlation between prediabetes and vitamin D, measurement of 
25OHD3 levels in patients with prediabetes is important because 
of the worldwide problem of vitamin D deficiency. However, more 
studies are necessary in order to reach a conclusion regarding the 
correlation between prediabetes and vitamin D deficiency.
CONCLUSION
Our study did not find any association between 25OHD3 and 
prediabetes. Low serum vitamin D was found in both groups, 
which is consistent with the worldwide vitamin D deficiency, 
thus making it difficult to analyze the relationship between pre-
diabetes and vitamin D deficiency.
Prediabetes is an early stage of diabetes. Any action that could 
prevent or delay the metabolic process that will lead to diabetes has 
great importance. Our study contributes towards the scarce litera-
ture on vitamin D and prediabetes by adding information about 
a South American country with an ethnically mixed population.
Table 2. Biochemical characteristics of the prediabetic and euglycemic 
groups
Prediabetic group 
n = 38
Euglycemic group 
n = 15
P
Glycemia (mg/dl) 104.9 ± 10.1 90.2 ± 5.3 0.03 
GTT 75 g (mg/dl) 145.5 ± 23.5 101.7 ± 21.4 < 0.0001 
Cholesterol (mg/dl) 191.8 ± 37.6 225.0 ± 36.3 0.005 
HDL cholesterol (mg/dl) 47.6 ± 9.9 55.6 ± 17.6 0.04 
LDL cholesterol (mg/dl) 112.9 ± 34.4 144.9 ± 31.0 0.003 
Triglycerides (mg/dl) 156.1 ± 81.7 121.8 ± 62.4 ns 
AST (U/l) 28.6 ± 6.63 25.6 ± 6.8 ns 
ALT (U/l) 28.8 ± 12.8 25.4 ± 8.7 ns 
Uric acid (mg/dl) 6.6 ± 1.5 5.1 ± 1.4 0.003 
Microalbuminuria (µg/min) 30.60 ± 88.0 5.2 ± 3.3 0.02 
Serum insulin (mUI/ml) 14.83 ± 17.4 6.6 ± 4.4 ns 
HOMA-IR 3.9 ± 4.7 1.2 ± 0.5 ns 
WC/height ratio 0.6 ± 0.07 0.5 ± 0.09 ns 
25OHD3 (ng/ml) 29.1 ± 11.8 26.87 ± 9.2 ns
Mean ± standard deviation. ns = not significant; GTT = glucose tolerance test; 
HDL = high-density lipoprotein; LDL = low-density lipoprotein; AST = aspartate 
aminotransferase; ALT = alanine aminotransferase; HOMA-IR = homeostasis model 
assessment - insulin resistance.
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